OpenPV Signal Explorer
FAERS disproportionality dashboard
Reaction

Skin Odour Abnormal reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 3,884 reports · 76 co-occurring drugs

As of the last recalculation, Skin Odour Abnormal appears in 3,884 FAERS reports alongside 76 co-occurring drug terms. The strongest observed disproportionality signal is DAPSONE (PRR 11.1).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Dapsone2211.111.1
Daspone1910.510.5
Dapsone Gel, 5%1910.510.5
Icosapent Ethyl159.59.5
Orlistat336.96.9
Zinc316.86.8
Zinc Chloride316.76.7
Minocycline146.56.5
Zinc Gluconate316.46.4
Rifampicin126.46.4
Moxifloxacin155.75.7
Mometasone175.05.0
Testosterone Cypionate84.84.8
Moxifloxacin Hydrochloride184.84.8
Rizatriptan Benzoate94.84.8
Elexacaftor, Tezacaftor, And Ivacaftor114.74.7
Thyroid, Porcine94.54.5
Progesterone174.04.0
Lubiprostone74.04.0
Human Insulin93.93.9
Misoprostol73.93.9
Rifampin103.73.7
Fulvestrant213.43.4
Mirabegron233.23.2
Diroximel Fumarate73.23.2
Calcium, Magnesium, Potassium, And Sodium Oxybates53.13.1
Vilazodone Hydrochloride52.92.9
Armodafinil112.82.8
Isotretinoin252.72.7
Avapritinib62.72.7
Ziprasidone Mesylate72.62.6
Sildenafil Citrate612.62.6
Oral Semaglutide352.62.6
Nicotine192.52.5
Ribavirin302.52.5
Somatropin342.52.5
Lisdexamfetamine Dimesylate152.42.4
Glecaprevir And Pibrentasvir52.42.4
Sodium Oxybate292.42.4
Rifaximin92.32.3
Peginterferon Alfa-2A232.32.3
Atomoxetine Hydrochloride102.32.3
Teriparatide472.22.2
Linaclotide112.22.2
Niraparib92.22.2
Liraglutide202.22.2
Lacosamide152.22.2
Enzalutamide232.12.1
Velpatasvir And Sofosbuvir52.12.1
Bictegravir Sodium, Emtricitabine, And Tenofovir Alafenamide Fumarate72.12.1
Mometasone Furoate And Formoterol Fumarate Dihydrate62.12.1
Ivacaftor32.02.0
Exenatide181.81.8
Vemurafenib41.81.8
Bimekizumab71.81.8
Dimethyl Fumarate391.71.7
Abaloparatide91.61.6
Canagliflozin91.61.6
Onabotulinumtoxina231.61.6
Alirocumab71.51.5
Varenicline Tartrate221.51.5
Levonorgestrel541.41.4
Palbociclib241.41.4
Paliperidone Palmitate81.31.3
Minoxidil111.31.3
Dulaglutide211.31.3
Droxidopa51.21.2
Dupilumab1031.11.1
Relugolix51.11.1
Evolocumab331.11.1
Tirzepatide301.01.0
Nirmatrelvir And Ritonavir101.01.0
Minoxidil Foam 5% (Womens)61.01.0
Etonogestrel80.90.9
Salicylic Acid40.40.4
Adapalene40.10.1

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.